Eric Easom
Chief Executive Officer at AN2 Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: AN2 Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AN2 Therapeutics Inc. May 22, 202568.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | AN2 Therapeutics Inc. | Grant or award | +112,250 | — | — |
| Jun 2, 2025 | AN2 Therapeutics Inc. | Open-market purchase | +10,000 | $1.07 | $10,700 |
| Feb 26, 2025 | AN2 Therapeutics Inc. | Grant or award | +145,250 | — | — |
| Nov 18, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +50,000 | $1.00 | $50,000 |
| Mar 15, 2024 | AN2 Therapeutics Inc. | Grant or award | +99,000 | — | — |
| Jan 2, 2024 | AN2 Therapeutics Inc. | Open-market sale | −2,777 | $20.09 | $55,790 |
| May 15, 2023 | AN2 Therapeutics Inc. | Open-market purchase | +10,000 | $5.38 | $53,800 |
Questions about Eric Easom
What boards is Eric Easom on?
Eric Easom sits on the board of AN2 Therapeutics Inc.
What company is Eric Easom the CEO of?
Eric Easom is Chief Executive Officer of AN2 Therapeutics Inc.
How long has Eric Easom served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.